참고문헌
- Pollack A, Zagars G and Swanson D. Muscle-invasive bladder cancer treated with external bearn radiotherapy: Prognostic factors. Int J Radiat Oncol Biol Phys 1994;30:267-277
- Gospodarowicz MK, Hawkins MV, Rawling GA, et al. Radical radiotherapy for muscle invasive transitional cell carcinoma of the bladder: Failure analysis. J Urol 1989;142:1448-1454 https://doi.org/10.1016/S0022-5347(17)39122-X
- Mameghan H, Fisher R, Mameghan J, et al. Analysis of failure following definitive radiotherapy for invasive transitional cell carcinorna of the bladder. Int J Radiat Oncol Biol Phys 1995;31:247-254 https://doi.org/10.1016/0360-3016(94)E0135-7
- Arias F, Dominguez MA, Martinez E, et al. Chernotherapy for muscle invading bladder carcinoma. Final report of a single institutional organ-sparing program. Int J Radiat Oncol Biol Phys 2000;47:373-378 https://doi.org/10.1016/S0360-3016(00)00444-2
- American Joint Committee on Cancer. Manual for staging of cancer. 5th ed. Philadelphia, New York; Lippincott Co, 1997:41-46
- Kaplan EL and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481 https://doi.org/10.2307/2281868
- Cox DR. Regression models and life tables. J R Statis Soc B 1972;34:187-220
- Jenkins BJ, Blandy JP, Caulfield MJ, et al. Reappraisal of the role of radical radiotherapy and salvage cystectomy in the treatment of invasive bladder cancer. Br J Urol 1988;62:343-346 https://doi.org/10.1111/j.1464-410X.1988.tb04362.x
- DeNeve W, Lybeert ML, Goor C, et al. Radiotherapy for T2 and T3 carcinoma of the bladder : The influence of overall treatment time. Radiat Oncol 1995;36:183-188 https://doi.org/10.1016/0167-8140(95)01586-6
- Koiso K, Shipley W, Keuppens F, et al. The status of bladder preserving therapeutic strategies in the management of patients with muscle invasive bladder cancer. Int J Urol 1995;2(Suppl 2):49-57
- Maciejewski B and Majewski S. Dose fractionation and tumor repopulation in radiotherapy for bladder cancer. Radiother Oncol 1991;21:163-170 https://doi.org/10.1016/0167-8140(91)90033-D
-
Dubben HH. Local control.
$TCD_50$ , and dose timeprescription habits in radiotherapy of head and neck tumors. Radioth Oncol 1994;32:197-200 https://doi.org/10.1016/0167-8140(94)90018-3 - Van Putten WLJ, Van der Sangen MJC, Hoekstra CJM and Levendag PC. Dose fractionation and overall treatment time in radiation therapy : The effects on local control for cancer of the larynx. Radioth Oncol 1994;30:97-108 https://doi.org/10.1016/0167-8140(94)90038-8
- Withers HR, Peters LJ, Taylor JMG, et al. Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions. Int J Radiat Oncol Biol Phys 1995;33:549-562 https://doi.org/10.1016/0360-3016(95)00228-Q
- Saunders MI, Dlsche S, Barret A, Parmar MK, Harvey A and Gibson D. Randomized multicenter trial of CHART versus conventional radiotherapy in head and neck and nonsmall cell cancer: A interim report. Br J Cancer 1996;73:1455-1462 https://doi.org/10.1038/bjc.1996.276
- Horiot JC, Bontemps P, Van den Bogaert W, et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers : results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-121 https://doi.org/10.1016/S0167-8140(97)00079-0
- Moonen L, Voet HVD, De Nus R, Horenblas S, Hart AAM and Bartelink H. Muscle invasive bladder cancer treated with external beam radiation: Influence of total dose, overall treatment time, and treatment interruption on local control. Int J Radiat Oncol Biol Phys 1998;42:525-530 https://doi.org/10.1016/S0360-3016(98)00263-6
- Morisson R. The results of treatment of cancer of the bladder-a clinical contribution. Clin Radiol 1975;26:67-75 https://doi.org/10.1016/S0009-9260(75)80017-1
- Naslund I, Nilsson B and Littbrand B. Hyperfractionated radiotherapy of bladder cancer: A 10 year follow up of a randomized clinical trial. Acta Oncol 1994;33:397-402 https://doi.org/10.3109/02841869409098435
- Jacobsen AB, Lunde S, Ous S, et al. T2/T3 bladder carcinomas treated with definitive radiotherapy with emphasis on flow cvtometric DNA ploidy values. Int J Rad Oncol Biol Phys 1989;17:923-929 https://doi.org/10.1016/0360-3016(89)90137-5
- Turner S, Swindell R, Bowl N, et al. Bladder movement during radiation therapy for bladder cancer: Implication for treatment planning. Int J Radiat Oncol Biol Phys 1994;30:199-200
- Marks LB and Shipley WU. Techniques for external beam irradiation of patients with invasive carcinoma of the urinary bladder. In : Levitt, S. H., ed. Technologic basis of radiotherapy : Practical clinical applications, 2nd ed. Philadelphia : Lee & Febiger; 1992:335-341
- Sur RK, clinkard J, Jones WG, et al. Changes in target volume during radiotherapy treatment of invasive bladder cancer. Clin Oncol 1993;5:30-33 https://doi.org/10.1016/S0936-6555(05)80693-4
- Cole D, Durrant K, Robert J, et al. A pilot study of accelerated fractionation in the radiotherapy of invasive carcinoma of the bladder. Br J Radiol 1992;65:792-798 https://doi.org/10.1259/0007-1285-65-777-792
- Shipley WU, Prout GR Jr , Einstein AB, et al. Treatment of invasive bladder cancer by cisplatin and radiation in patients unsuited for surgery. JAMA 1987;258:931-935 https://doi.org/10.1001/jama.258.7.931
- Scher HI, Herr HW, Sternberg C, et al. Neoadjuvant chemotherapy for invasive bladder cancer. Experience with the MVAC regimen. Br J Urol 1989;64:250-256 https://doi.org/10.1111/j.1464-410X.1989.tb06008.x
- Sauer R, Dunst J, Altendorf-Hofmann A, et al. Radiotherapy with and without cisplatin in bladder cancer. Int J Radiat Oncol Biol Phys 1990;19:687-691 https://doi.org/10.1016/0360-3016(90)90497-8
- Begg A. Cisplatin and radiation: Interaction probabilities and other therapeutic possibilities. Int J Radiat Oncol Biol Phys 1990;19:1183-1189 https://doi.org/10.1016/0360-3016(90)90226-A
- Flentje M, Eble M and Haner U. Additive effects of cisplatin and radiation in human tumor cells under oxic conditions. Radiother Oncol 1992;24:60-63 https://doi.org/10.1016/0167-8140(92)90355-X
- Mothersill C, Seymour CB, Cusak A, O'Brien A, Butler M. The effect of radiation and cytotoxic platinum compounds on the growth of normal and tumor bladder explant cultures. Acta Oncol 1990;29:179-184 https://doi.org/10.3109/02841869009126542
- Tester W, Porter A, Asbell S, et al. Combined modality program with possible organ preservation for invasive bladder carcinoma: Results of RTOG protocol 85-12. Int J Radiat Oncol Biol Phys 1993;25:783-790 https://doi.org/10.1016/0360-3016(93)90306-G
- Dunst J, Sauer R, Schott KM, Kuhn R, Wittekind C and Altendorf-Hofman A. Organ-sparing treatment of advanced A. Organ- sparing treatment of advanced bladder cancer. A 10-year experience. Int J Radiat Oncol Biol Phys 1994;30:261-266
- Sauer R, Birkenhake S, Khun R, Wittekind C, Schortt KM and Martus P. Efficacy of radiochemotherapy with platin derivatives compared to radiotherapy alone in organ-sparing treatment of bladder cancer. Int J Radiat Oncol Biol Phys 1998;40:121-127 https://doi.org/10.1016/S0360-3016(97)00579-8
- Tester W, Caplan R, Heaney J, et al. Neoadjuvant combined program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group Phase II trial 8802. J Clin Oncol 1996;14:119-126 https://doi.org/10.1200/JCO.1996.14.1.119
- Shipley WU, Winter KA, Kaufman DS, et al. Phase III trial of neoadjuvant chemotherapy in patients with invasive bladder cancer treated with selective bladder preservation by combined radiation therapy and chemotherapy. Initial results of Radiation Therapy Oncology Group. 89-03. J Clin Oncol 1998;16:3576-3583 https://doi.org/10.1200/JCO.1998.16.11.3576